Functional interaction between mGlu 5 and NMDA receptors in a rat model of Parkinson's disease (Q45279113)

11 December 2017

Functional interaction between mGlu 5 and NMDA receptors in a rat model of Parkinson's disease (English)

1 reference

11 December 2017

Nathalie Turle-Lorenzo

1

1 reference

11 December 2017

Nathalie Breysse

2

1 reference

11 December 2017

Christelle Baunez

3

1 reference

11 December 2017

Marianne Amalric

4

1 reference

11 December 2017

language of work or name

1 reference

22 February 2005

1 reference

11 December 2017

1 reference

11 December 2017

179

1 reference

11 December 2017

1

1 reference

11 December 2017

117-127

1 reference

https://scigraph.springernature.com/pub.10.1007/s00213-005-2202-x

11 December 2017

0 references

cites work

Behavioural pharmacology of glutamate in the basal ganglia

1 reference

12 December 2020

N-Methyl-d-Aspartate Antagonists in the Treatment of Parkinson's Disease

1 reference

12 December 2020

Activation of metabotropic glutamate receptor 5 has direct excitatory effects and potentiates NMDA receptor currents in neurons of the subthalamic nucleus.

1 reference

12 December 2020

Behavioral and anatomical effects of long-term L-dihydroxyphenylalanine (L-DOPA) administration in rats with unilateral lesions of the nigrostriatal system

1 reference

12 December 2020

The role of excitatory amino acids in experimental models of Parkinson's disease.

1 reference

12 December 2020

Enhancement of NMDA responses by group I metabotropic glutamate receptor activation in striatal neurones

1 reference

12 December 2020

2-Methyl-6-(phenylethynyl)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor antagonist

1 reference

12 December 2020

NMDA antagonists potentiate antiparkinsonian actions of L-dopa in monoamine-depleted rats

1 reference

12 December 2020

Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson's disease.

1 reference

12 December 2020

Metabotropic glutamate subtype 5 receptors modulate locomotor activity and sensorimotor gating in rodents

1 reference

12 December 2020

Stimulation of basal and L-DOPA-induced motor activity by glutamate antagonists in animal models of Parkinson's disease

1 reference

12 December 2020

Selective mGluR5 antagonists MPEP and SIB-1893 decrease NMDA or glutamate-mediated neuronal toxicity through actions that reflect NMDA receptor antagonism

1 reference

12 December 2020

Metabotropic glutamate receptor 5 mediates the potentiation of N-methyl-D-aspartate responses in medium spiny striatal neurons.

1 reference

12 December 2020

Metabotropic glutamate 5 receptor blockade alleviates akinesia by normalizing activity of selective basal-ganglia structures in parkinsonian rats.

1 reference

12 December 2020

Simple and choice reaction time performance following unilateral striatal dopamine depletion in the rat. Impaired motor readiness but preserved response preparation

1 reference

12 December 2020

Lack of effect of LY314582 (a group 2 metabotropic glutamate receptor agonist) on phencyclidine-induced locomotor activity in metabotropic glutamate receptor 2 knockout mice

1 reference

12 December 2020

The mGluR5 antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP) potentiates PCP-induced cognitive deficits in rats

1 reference

12 December 2020

Choice reaction time after levodopa challenge in parkinsonian patients

1 reference

12 December 2020

Characterization of MK-801-induced behavior as a putative rat model of psychosis.

1 reference

12 December 2020

Dorsal pallidum as a functional motor output of the corpus striatum

1 reference

12 December 2020

Functional Interaction Between NMDA and mGlu5 Receptors: Effects on Working Memory, Instrumental Learning, Motor Behaviors, and Dopamine Release

1 reference

12 December 2020

Chronic but not acute treatment with a metabotropic glutamate 5 receptor antagonist reverses the akinetic deficits in a rat model of parkinsonism.

1 reference

12 December 2020

L-DOPA-induced dyskinesia in the rat is associated with striatal overexpression of prodynorphin- and glutamic acid decarboxylase mRNA.

1 reference

12 December 2020

MK-801 potentiates dopaminergic D1 but reduces D2 responses in the 6-hydroxydopamine model of Parkinson's disease

1 reference

12 December 2020

The mGluR5 antagonist MPEP, but not the mGluR2/3 agonist LY314582, augments PCP effects on prepulse inhibition and locomotor activity

1 reference

12 December 2020

Aminoadamantanes as NMDA receptor antagonists and antiparkinsonian agents--preclinical studies.

1 reference

12 December 2020

L-DOPA-induced dyskinesia in the intrastriatal 6-hydroxydopamine model of parkinson's disease: relation to motor and cellular parameters of nigrostriatal function

1 reference

12 December 2020

Activation of type 5 metabotropic glutamate receptors enhances NMDA responses in mice cortical wedges

1 reference

12 December 2020

Blockade of the metabotropic glutamate receptor subtype 5 (mGluR5) produces antiparkinsonian-like effects in rats

1 reference

12 December 2020

Depletion of dopamine in the caudate nucleus but not in nucleus accumbens impairs reaction-time performance in rats.

1 reference

12 December 2020

Molecular diversity of glutamate receptors and implications for brain function

1 reference

12 December 2020

Complex deficits on reaction time performance following bilateral intrastriatal 6-OHDA infusion in the rat

1 reference

12 December 2020

Characterization of enhanced behavioral responses to L-DOPA following repeated administration in the 6-hydroxydopamine-lesioned rat model of Parkinson's disease

1 reference

12 December 2020

Primate models of movement disorders of basal ganglia origin

1 reference

12 December 2020

Differential visualization of dopamine and norepinephrine uptake sites in rat brain using [3H]mazindol autoradiography.

1 reference

12 December 2020

(RS)-2-chloro-5-hydroxyphenylglycine (CHPG) activates mGlu5, but no mGlu1, receptors expressed in CHO cells and potentiates NMDA responses in the hippocampus

1 reference

12 December 2020

Pharmacology and functions of metabotropic glutamate receptors

1 reference

12 December 2020

Does the blockade of excitatory amino acid transmission in the basal ganglia simply reverse reaction time deficits induced by dopamine inactivation?

1 reference

12 December 2020

NMDA receptor antagonists ameliorate the stepping deficits produced by unilateral medial forebrain bundle injections of 6-OHDA in rats

1 reference

12 December 2020

Two distinct signaling pathways upregulate NMDA receptor responses via two distinct metabotropic glutamate receptor subtypes.

1 reference

12 December 2020

Inhibitory effects of MPEP, an mGluR5 antagonist, and memantine, an N-methyl-D-aspartate receptor antagonist, on morphine antinociceptive tolerance in mice

1 reference

12 December 2020

Metabotropic glutamate receptors 1 and 5 differentially regulate CA1 pyramidal cell function.

1 reference

12 December 2020

Molecular diversity and functions of glutamate receptors

1 reference

12 December 2020

10.1007/S00213-005-2202-X

Identifiers

DOI

1 reference

Dimensions Publication ID

11 December 2017

0 references

1 reference